Journal of Mid-life Health Journal of Mid-life Health
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission | Subscribe | Advertise Users Online: 128  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 




 
 Table of Contents 
EDITORIAL
Year : 2018  |  Volume : 9  |  Issue : 1  |  Page : 1  

Dyslipidemia and Breast Cancer


1 Department of Obstetrics and Gnnaecology, PGIMER, Chandigarh, India
2 Department of Obstetrics and Gynaecology, GMC, Jammu, Jammu and Kashmir, India

Date of Web Publication14-Mar-2018

Correspondence Address:
Neelam Aggarwal
Department of Obstetrics and Gnnaecology, PGIMER, Chandigarh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmh.JMH_24_18

Rights and Permissions

How to cite this article:
Aggarwal N, Sharma S. Dyslipidemia and Breast Cancer. J Mid-life Health 2018;9:1

How to cite this URL:
Aggarwal N, Sharma S. Dyslipidemia and Breast Cancer. J Mid-life Health [serial online] 2018 [cited 2018 Dec 12];9:1. Available from: http://www.jmidlifehealth.org/text.asp?2018/9/1/1/227248



The current issue of the Journal of Midlife Health will be the last issue of our tenure spanning over 2 years of both Dr. Neelam Aggarwal and me, as chief editors of the Journal of Midlife Health.

As we all know that with increased expectancy of life, a female is spending nearly one-third of her life in menopause. Hence, during this postreproductive period, a woman needs preventive health care to prevent and contain noncommunicable diseases such as cancer, cardiovascular diseases, osteoporosis, and neurological disorders.

The article on association of dyslipidemia increased insulin resistance, and serum CA 15-3 with increased risk of breast cancer (BC) highlights that BC is the most common cancer affecting female individuals in the world. Although in India, incidence is significantly lower than in western countries. With an annual incidence of approximately 144,000 cases, BC has now become the most common cancer affecting female individuals in urban India.

In the past few years, extensive efforts have been dedicated to understanding the relationship between dyslipidemia, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and BC risk. This study suggests that dyslipidemia and disturbed glucose metabolism are correlated with BC and supports the hypothesis that total cholesterol, low-density lipoprotein cholesterol, triglycerides, and serum glucose are important risk factors in the development of BC. Hence, there is a need to reinforce the importance of controlling these risk factors by lifestyle modification such as diet, exercise, yoga, meditation, and medication whenever or wherever necessary.

“Coming together is a beginning, keeping together is progress, working together is success” (Henry Ford) – holds good for both Dr. Neelam and me. We both have enjoyed working together and have been able to take JMH to further level by its accreditation in Scopus, though we still have a long way to go.

We would like to take this opportunity to profusely thank our editorial board, the peer reviewers, the authors, governing council of the last 2 years, Ms. Arshia from the IMS office and the entire staff of Medknow especially Mr. Sandeep Chugh. We welcome and congratulate the new team of chief editors, Dr. Annil Mahajan and Dr. Ranu Patni, with the hope that they shall raise the standards of JMH to even more heights.




Dr. Sudhaa Sharma





Dr. Neelam Aggarwal







 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed645    
    Printed57    
    Emailed0    
    PDF Downloaded158    
    Comments [Add]    

Recommend this journal